MYELODYSPLASTIC SYNDROMES (MDS)
Clinical trials for MYELODYSPLASTIC SYNDROMES (MDS) explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROMES (MDS) trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROMES (MDS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study aims to prevent relapse in tough blood cancers after transplant
Disease control Not yet recruitingThis study looks at two ways of giving donor immune cells after a stem cell transplant to prevent cancer from coming back in people with hard-to-treat acute myeloid leukemia or myelodysplastic syndromes. About 200 participants will be randomly assigned to receive donor cells eith…
Matched conditions: MYELODYSPLASTIC SYNDROMES (MDS)
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Could a common diabetes pill ease anemia in MDS patients?
Symptom relief Not yet recruitingThis study tests whether dapagliflozin, a drug used for diabetes, can improve anemia in people with lower-risk myelodysplastic syndromes (MDS). Anemia causes fatigue and often requires blood transfusions. About 37 adults will take the pill daily for 24 weeks to see if their hemog…
Matched conditions: MYELODYSPLASTIC SYNDROMES (MDS)
Phase: PHASE2 • Sponsor: Seug yun Yoon, MD • Aim: Symptom relief
Last updated May 22, 2026 14:05 UTC
-
New registry to map MDS landscape across asia
Knowledge-focused Not yet recruitingThis study is a registry that will gather information from about 500 adults in Asia who have been diagnosed with myelodysplastic syndromes (MDS). The goal is to learn more about the patients' backgrounds, the treatments they receive, and how their disease progresses over time. No…
Matched conditions: MYELODYSPLASTIC SYNDROMES (MDS)
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC